Table 2 Primer and recurrence pathology in recurrence-positive patients.

From: Prediction of recurrence using hematologic and urinary markers in intravesical Bacillus calmette Guerin treated bladder cancer

 

First pathology

Recurrence pathology

TaLG

2(16.7)

0(0)

TaHG

2(16.7)

1(8.3)

T1LG

0(0)

3(25)

T1HG

8(66.7)

3(25)

T2HG

0(0)

5(41.7)